A new catheter procedure to treat thickened heart muscle
Part of Heart & circulation clinical trials.
This study tests a new, less invasive procedure called SESAME that uses a special catheter to carefully trim the thickened heart muscle wall (septum) to improve blood flow and reduce symptoms. It's for people with hypertrophic cardiomyopathy or those at risk of obstruction during mitral valve replacement.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 21 years or older.
- You need to have either hypertrophic cardiomyopathy with symptoms or be planning a mitral valve replacement where there's a risk of heart obstruction.
- You must have severe symptoms like shortness of breath or chest pain despite treatment.
- You must be willing to try this new procedure over standard treatments.
- You cannot be pregnant, have severe kidney disease, or have a mechanical aortic valve.
- Your heart team must agree that this procedure is safe and appropriate for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a device called a coronary sinus reducer for people with hypertrophic cardiomyopathy (a condition where the heart muscle is thickened) who still have symptoms like chest pain. The device is placed in a vein of the heart to improve blood flow and reduce symptoms.
This study tests whether a 24-week exercise program can improve exercise tolerance in people with hypertrophic cardiomyopathy (a thickened heart muscle). You may be asked to use phone-based tools and complete surveys during training.
This trial tests a new treatment that uses radiofrequency energy (similar to heat) to shrink the thickened heart muscle blocking blood flow. It is for people with obstructive hypertrophic cardiomyopathy who have symptoms despite medication and are not able or willing to have heart surgery.
This trial studies surgery that removes part of the thick heart muscle while the heart is still beating to relieve a blockage that makes blood leaving the heart harder. It may help people with hypertrophic obstructive cardiomyopathy whose symptoms persist despite medication.
This trial uses a special CT scan to create a 3D model of your heart's blood flow. It aims to see if this model can help doctors better predict how well treatments work for people with a thick heart muscle that blocks blood flow.
This study looks at people who have had surgery to reshape the left side of the heart for a specific type of thickened heart muscle (apical hypertrophic cardiomyopathy). It helps doctors understand how well this surgery works in patients without a large pressure difference across the heart valve.
Hear when a new Hypertrophic Cardiomyopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.